Nick Kalivas of Invesco suggests a growth strategy that lowers investors’ risk from the S&P 500’s Big Tech concentration.

But a look at the most recent quarterly update shows it still has plenty of growth potential ahead. Revenue grew 16% year ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

Vital Farms raises revenue guidance and expands production. Learn why VITL stock offers solid growth prospects as the company ...

Wall Street's dramatic reaction to DeepSeek's AI announcement on Monday created compelling opportunities in unlikely places.

Wall Street analysts forecast the company will manage a 4.3% revenue increase in 2025, accompanied by a 1.5% rebound in EPS.

So you've got $1,000 (or $10,000 or $50,000) burning a hole in your pocket -- and you want to invest in some growth stocks.

Some of the most reliable millionaire-maker stocks are well-established companies with year after year of revenue growth and ...

It reported sales of $48.4 billion and earnings of $8.02 per share, compared to the consensus estimates of $47.0 billion and ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

IBM stock, with 45% returns since the beginning of 2024, has outperformed the S&P 500 index, up 27%. Strong demand trends for its software business has driven its stock price growth lately. But, if ...

These four top dividend stocks offer dependable passive income streams and solid total return, and they are too cheap to ...